Latest News
Grape King Biotech Accelerates Global Footprint: UVACO Pro-Partner Penetrates Malaysia; Functional Raw Ingredients Expand Across 60 Countries
2026-06-29

Grape King Biotech (葡萄王生技; 1707 TT) is executing an aggressive multi-pronged international expansion strategy across its direct-selling business, proprietary functional ingredient distribution channels, and global ODM/OEM platforms.

Direct Selling: UVACO Pro-Partner Malaysia Launch

The group's direct-selling subsidiary, UVACO Pro-Partner (葡眾), initiated trial operations of its new regional headquarters in Kuala Lumpur, Malaysia, with a formal grand opening scheduled for August 17.

  • Initial SKU Rollout: To capture Malaysia's rapidly growing wellness and preventative health market, Pro-Partner's initial launch features six of its top-selling Taiwanese formulations, including: Liprofac Antrodia Cinnamomea Capsules (樟芝益膠囊), Oatmeal Nutrition Pack (葡眾餐包), FemiRely Botanical Beverage Mix (欣悅康沖泡飲), Toothpaste (貝益潔牙膏), Aloe Vera Gel (蘆露蘆薈膠), and YaYa Mini Soothing Cream (舒緩膏).
  • Market Engagement: The executive team will host a comprehensive market preview at the Four Seasons Hotel Kuala Lumpur, which is projected to draw over 500 Taiwanese leaders and potential Malaysian joint-venture partners to secure local commercial momentum.

B2B Functional Ingredients & Global ODM Expansion

Grape King is leveraging its proprietary strains, advanced bio-fermentation platforms, and high-purity functional ingredient platforms to scale its B2B industrial segment:

  • Vitafoods Europe Traction: The company debuted its proprietary fungal mycelia and probiotic ingredient profiles at Vitafoods Europe, drawing interest from Western brand owners, contract manufacturers, and ingredient distributors. Its standardized Lion’s Mane Mycelium ingredient, enriched with high concentrations of Erinacine A, emerged as a high-demand asset, with multiple international clients securing samples for product formulation and commercial procurement talks.
  • Global Distribution Network: Grape King's international contract manufacturing division is in advanced negotiations with major global ingredient distributors for exclusive out-licensing and sales rights. Once finalized, this partnership will distribute Grape King's functional raw ingredients into over 60 countries.
  • Trade Show Frameworks: To capture domestic and international brand-owner accounts, Grape King is returning to the BIO Asia–Taiwan exhibition after a 12-year absence. Under the theme "The Preferred Choice for Contract Manufacturing," the company will showcase its end-to-end ODM capabilities across nine major dosage forms, including powder sticks, softgels, tablets, functional jellies, and liquid fills. The group will follow this in September by participating in Vitafoods Asia to lock in H2 2026 and FY2027 manufacturing orders.
  • Executive Outlook: Chairman and CEO Andrew Hwei stated that Grape King is systematically accumulating its next-generation growth assets by elevating its international profile, mapping corporate capabilities directly to specialized B2B demands, and introducing premium, clinically backed formulations.

Resource:葡萄王加速海外布局 UVACO葡眾進軍馬來西亞、功能性原料搶攻全球市場

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
© 2026 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978